Non-invasive prenatal testing is becoming commonplace, but, in addition, other tests using only a blood sample are being developed and will have a significant impact, notably in oncology.

An exceptional arrangement concluded for access to the HeLa cell line sequence highlights the problems involved in studies on « old » samples obtained before ethical and privacy safeguards were in place.

There are now a number of cases in which non-invasive prenatal testing (NIPT) has detected signs of cancer in pregnant women. These unexpected findings raise a number of difficult questions regarding their communication ...

A recent paper shows that cancer patients using complementary therapies in addition to conventional treatment have distinctly worse outcomes. Analysis of the data shows that they are much more likely to refuse one component ...

Après les bombardements atomiques subis par les villes d’Hiroshima et de Nagasaki, un suivi à long terme des survivants irradiés et de leur descendance a été mis en place et se poursuit encore aujourd’hui. Ces études très ...

Comme on l’a dit et répété dans ces colonnes [1–3], la valeur prédictive des profils génétiques à base de Snip vendus par 23andMe, Navigenics et autres « entreprises DTC » (direct to consumer) est très faible pour ne pas ...